Inventor · Vancouver, BC, CA

Adam Judge

24Patents
13h-index
26Co-inventors
81Inventor score

Filing activity: Jun 30, 2005 → Oct 25, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8101741B2 Modified siRNA molecules and uses thereof Chemistry; Metallurgy 140 Active
US8188263B2 Modified siRNA molecules and uses thereof Chemistry; Metallurgy 132 Active
US8236943B2 Compositions and methods for silencing apolipoprotein B Emerging Cross-Sectional Technologies 128 Active
US8513403B2 Modified siRNA molecules and uses thereof Chemistry; Metallurgy 103 Active
US8283333B2 Lipid formulations for nucleic acid delivery Emerging Cross-Sectional Technologies 94 Active
US9074208B2 Modified siRNA molecules and uses thereof Chemistry; Metallurgy 88 Active
US9187748B2 Compositions and methods for silencing ebola virus gene expression Chemistry; Metallurgy 87 Active
US7807815B2 Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA Chemistry; Metallurgy 58 Expired
US7915399B2 Modified siRNA molecules and uses thereof Chemistry; Metallurgy 51 Active
US8227443B2 Silencing of CSN5 gene expression using interfering RNA Chemistry; Metallurgy 27 Active
US8598333B2 SiRNA silencing of genes expressed in cancer Emerging Cross-Sectional Technologies 21 Active
US9878042B2 Lipid formulations for delivery of therapeutic agents to solid tumors Emerging Cross-Sectional Technologies 19 Active
US9006191B2 Silencing of polo-like kinase expression using interfering RNA Chemistry; Metallurgy 17 Active
US8865675B2 Compositions and methods for silencing apolipoprotein B Chemistry; Metallurgy 9 Active
US8716464B2 Compositions and methods for silencing Ebola virus gene expression Chemistry; Metallurgy 9 Active
US11191849B2 Compositions and methods for delivering messenger RNA Chemistry; Metallurgy 4 Active
US11446383B2 Lipid formulations for delivery of therapeutic agents Emerging Cross-Sectional Technologies 3 Active
US11786598B2 Lipid formulations for delivery of therapeutic agents Emerging Cross-Sectional Technologies 3 Active
US11427823B2 Targeted compositions Chemistry; Metallurgy 2 Active
US12016929B2 Lipid formulations for delivery of therapeutic agents Emerging Cross-Sectional Technologies 1 Active
US12251470B2 Lipid nanoparticle formulations Chemistry; Metallurgy 0 Active
US12344675B2 Polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex Chemistry; Metallurgy 0 Active
US9222086B2 Compositions and methods for silencing genes expressed in cancer Chemistry; Metallurgy 0 Active
US12043833B2 Targeted compositions Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.